R2IBF’s R$400 Million Business Combination With RPH Pharma

Lefosse team included R2 IBF Participacoes on the transaction.BF Participac¸o~es S.A. (“R2IBF”), a leading player in the nuclear medicine sector, announced the business combination with RPH Pharma,…

This content is for Standard 1 Year members only.
Login Join Now
Laura Testa

Author: Laura Testa

This content is for Standard 1 Year members only.
Login Join Now